William Jones

Mr. Jones has over 20 years of commercial experience in the healthcare industry and has held leadership roles of increasing responsibility at Takeda Pharmaceuticals, Inc., Bristol-Myers Squibb, Boehringer-Ingelheim, NitroMed and AstraZeneca. He has significant experience in mass market product launches, including Excedrin Migraine, Abilify, Farxiga, Pradaxa, and BiDil. BJ has successfully built and led diverse commercial teams committed to addressing unmet patient needs across various therapeutic areas, including neuroscience (migraine, schizophrenia, bipolar, depression), CV (CHF, atrial fibrillation), diabetes (type 2 - oral and injectable), respiratory, GI, and infectious disease. He holds a Bachelor of Science degree from the U.S. Air Force Academy, a Master of Science degree in Industrial Engineering from Texas A&M University and an MBA from Stanford Graduate School of Business. Prior to joining the pharmaceutical industry, BJ served in the U.S. Air Force and earned the rank of Major.